Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-03-20Clinical Trial Update: Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients [Phase 2]
A Phase 2 clinical trial is evaluating Bosentan for stable severe chronic obstructive pulmonary disease; no results or definitive status are…
-
FDA approval · 2014-03-19FDA Approved: FORMOTEROL FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for formoterol fumarate (Mylan Pharmaceuticals Inc.). The action updates the product labeling and ma…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients [Phase 1]
A Phase 1 safety, pharmacokinetic and pharmacodynamic study of PUR0200 in COPD patients has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Long-term Safety Study for GSK573719/GW642444 in Japanese [Phase 3]
A long-term safety study of the COPD drug GSK573719/GW642444 in Japanese patients has completed Phase 3, and results were posted in March 20…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Chinese Community Smoking Cessation Project [NA]
A completed clinical trial update for a UCSF-sponsored smoking cessation project conducted in China, listing cardiovascular diseases, heart …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Endothelial Dysfunction in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
A completed clinical trial sponsored by the Ludwig Boltzmann Institute studied endothelial dysfunction during acute exacerbations of chronic…
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Early Telemedicine Training in Patients With COPD [NA]
A completed clinical trial evaluating early telemedicine training for patients with Chronic Obstructive Pulmonary Disease (COPD).
-
CLINICAL_TRIALS research · 2014-03-10Clinical Trial Update: Dyspnea Threshold During 6 Minutes Walk Test [NA]
This entry reports a completed clinical trial evaluating dyspnea threshold during the 6-minute walk test in chronic obstructive pulmonary di…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison [Phase 1]
Phase 1 trial completed comparing inhalation profiles for chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD
This completed clinical trial update investigates the prevalence of muscle wasting in COPD and its association with muscle weakness.
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Single Portable Pulse-dose-conserving Device vs. Combined Use of Stationary and Portable. [Phase 3]
Phase 3 trial comparing a single portable pulse-dose-conserving device against a combined stationary and portable setup for chronic obstruct…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Balance Training for Chronic Obstructive Pulmonary Disease (COPD)
A completed clinical trial update evaluating balance training for chronic obstructive pulmonary disease (COPD).
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing once-daily fluticasone furoate/vilanterol (100/25 mcg) to twice-daily fluticasone propionate/salmeterol (250/50 mcg)…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease [Phase 2]
GlaxoSmithKline completed a Phase 2 dose-ranging study of GSK573719 in chronic obstructive pulmonary disease; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD [Phase 3]
A 24-week Phase 3 trial evaluating GSK573719/vilanterol and components in COPD has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial comparing DISKUS and ELLIPTA inhaler devices for patients with chronic obstructive pulmonary disease completed, with results…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: 14729-D9831C00002- 1 Month Biopsy Study [Phase 2]
A Phase 2 COPD trial (1-month biopsy study) sponsored by AstraZeneca has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension. [Phase 1]
A Phase 1 single-dose study in patients with COPD-associated pulmonary hypertension has completed, and the results have been posted.
-
FDA approval · 2014-02-27FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Budesonide and Formoterol Fumarate Dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: NOWOX Oxygen Therapy Monitoring Device [NA]
The NOWOX Oxygen Therapy Monitoring Device trial conducted by Air Liquide SA for Chronic Obstructive Pulmonary Disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Efficacy of Simvastatin for the Treatment of COPD [Phase 3]
A Phase 3 trial evaluating the efficacy of simvastatin for chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: 28-day Repeat Dose Study of GSK573719 [Phase 2]
A Phase 2 28-day repeat-dose study of GSK573719 in chronic obstructive pulmonary disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 study comparing the combination GSK573719/GW642444 to GSK573719 alone and to tiotropium in chronic obstructive pulmonary disease h…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Home Mechanical Ventilation Effectiveness and Air Leaks
A completed clinical trial evaluated the effectiveness of home mechanical ventilation and issues with air leaks in patients with chronic res…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Airflow Limitation in Cardiac Diseases in Europe
GlaxoSmithKline-sponsored European trial evaluating airflow limitation in chronic obstructive pulmonary disease has completed.